The results demonstrated that abnormal CGB5 expression was significantly associated with OS in PAAD and STAD (Figure 5B), where increased CGB5 expression was linked to shorter OS in PAAD and STAD. This evidence concerns the gene CGB5 and pancreatic adenocarcinoma.